02.01.2013 Views

Speakers - Sachs Associates

Speakers - Sachs Associates

Speakers - Sachs Associates

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CONTACTS<br />

Dr Christof Böhler<br />

Chief Business Officer<br />

DDr Sven Rohmann<br />

Chief Business Officer<br />

ADDRESS<br />

Industriering 21<br />

9494 Ruggell<br />

Liechtenstein<br />

TELEPHONE<br />

+423 377 78 00<br />

FAX<br />

+423 377 78 99<br />

EMAIL<br />

info@pantec-biosolutions.com<br />

YEAR FOUNDED<br />

2005<br />

Pantec Biosolutions AG<br />

www.pantec-biosolutions.com<br />

FINANCIAL SUMMARY<br />

Pantec is funded by private investors and one VC company.<br />

The company is seeking new investors alongside existing shareholders in a new financing round.<br />

COMPANY PROFILE<br />

Pantec Biosolutions is the leading company for stable and controlled dermal delivery of large weight<br />

biopharmaceuticals. Our goal is to replace injection based medication of biologicals in selected disease areas<br />

with the help of a breakthrough dermal delivery method. The proprietary combination of P.L.E.A.S.E.® (Precise<br />

Laser Epidermal System) microporation technology with intradermal drug delivery allows easy to use, safe,<br />

rapid and painless application of infertility hormones and other large molecular weight biopharmaceuticals. This<br />

platform significantly improves precise drug uptake in addition to reducing treatment duration and avoiding the<br />

need for injections. This technology has significant potential to unlock a high unmet need of treatments requiring<br />

large molecular weight biopharmaceuticals.<br />

The company’s focus is in combining laser of laser microporation with drug delivery in the dermatology and<br />

immunology space.<br />

In addition P.L.E.A.S.E.® can also be used “stand alone” as a new category fractional ablative laser device to<br />

break new ground in aesthetic dermatology.<br />

MANAGEMENT<br />

Dr Boehler Christof, CEO<br />

Mr Bragagna Thomas, CTO<br />

Dr Dr med. Rohmann Sven, CBO<br />

Dr. Clemens Norbert, Clinical Director as permanent consultant<br />

Dr Kalia Yogeshvar N, Chief Scientific Advisor<br />

t back :: next u<br />

WELCOME PHARMA LICENSING GROUPS<br />

SPEAKERS<br />

PRESENTING COMPANIES SUPPORTING ORGANISATIONS<br />

ORGANISERS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!